Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares stood at 2.17 million during the last session, with the company’s beta value hitting 1.83. At the close
In the last trading session, 4.38 million Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) shares changed hands as the company’s beta touched 1.70. With the company’s per
In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 1.15 million shares changing hands with its beta currently measuring 1.72. Company’s recent per share
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.70 and has seen 2.31 million shares traded in the last trading session. The company,
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.70 and has seen 6.23 million shares traded in the last trading session. The company,
During the recent session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares were 52.52 million, with the beta value of the company hitting 1.75. At the
In the last trading session, 0.12 million shares of the Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) were traded, and its beta was 1.76. Most recently the
In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 0.23 million shares changing hands with its beta currently measuring 1.76. Company’s recent per share
Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) has a beta value of 1.75 and has seen 1.27 million shares traded in the last trading session. The company,
During the recent session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX)’s traded shares were 0.49 million, with the beta value of the company hitting 1.75. At the
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
